Skip to content

AFFILIATES:

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Menu
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Brookline Capital Markets
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT
Menu
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT

2020

FSD Pharma Inc. Announces US $10 Million Registered Direct Offering

Read More FSD Pharma Inc. Announces US $10 Million Registered Direct OfferingContinue

NervGen Pharma Corp. Completes $6.45 Million Public Offering

Read More NervGen Pharma Corp. Completes $6.45 Million Public OfferingContinue

CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants

Read More CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and WarrantsContinue

Nuveen Dynamic Municipal Opportunities Fund Attracts $780.0 Million

Read More Nuveen Dynamic Municipal Opportunities Fund Attracts $780.0 MillionContinue

Creatd, Inc., Formerly Jerrick Media Holdings, Inc., Announces Pricing of $7,762,500 Public Offering

Read More Creatd, Inc., Formerly Jerrick Media Holdings, Inc., Announces Pricing of $7,762,500 Public OfferingContinue

Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock

Read More Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common StockContinue

InMed Announces Pricing of US $8.0 Million Public Offering and Listing on the Nasdaq Capital Market Under the Symbol “INM”

Read More InMed Announces Pricing of US $8.0 Million Public Offering and Listing on the Nasdaq Capital Market Under the Symbol “INM”Continue

9 Meters Biopharma, Inc. Prices Public Offering of Common Stock

Read More 9 Meters Biopharma, Inc. Prices Public Offering of Common StockContinue

BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market

Read More BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-MarketContinue

BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market

Read More BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-MarketContinue

Page navigation

Previous PagePrevious 1 … 5 6 7 8 Next PageNext

HEADQUARTERS

Brookline Capital Markets

600 Lexington Avenue, 30th Floor
New York, New York 10022
(646) 603-6716

Linkedin

LINKS

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Securities Offered Through Arcadia Securities, LLC – Member FINRA/SIPC

FINRA BROKER CHECK

Arcadia Securities LLC Form CRS

Arcadia Securities LLC Reg BI

Order routing information can be accessed through the following link by inputting Arcadia Securities: https://www.orderroutingdisclosure.com/.

© 2025 Brookline Capital Markets. All rights reserved

© 2021 Brookline Capital Markets. All rights reserved